CTL escape and increased viremia irrespective of HIV-specific CD4 + T-helper responses in two HIV-infected individuals

We investigated whether development of mutations leads to loss of CD8 T-cell recognition in HIV-1 infection and is possibly linked to alterations in HIV-1-specific CD4 + T-cell responses in 2 HIV-infected individuals. In patient, H434 full genome sequencing of HIV-1 biological clones at early and la...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology (New York, N.Y.) N.Y.), 2006-02, Vol.345 (1), p.209-219
Hauptverfasser: Geels, Mark J., Jansen, Christine A., Baan, Elly, De Cuyper, Iris M., van Schijndel, Gijs J.M., Schuitemaker, Hanneke, Goudsmit, Jaap, Pollakis, Georgios, Miedema, Frank, Paxton, William A., van Baarle, Debbie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We investigated whether development of mutations leads to loss of CD8 T-cell recognition in HIV-1 infection and is possibly linked to alterations in HIV-1-specific CD4 + T-cell responses in 2 HIV-infected individuals. In patient, H434 full genome sequencing of HIV-1 biological clones at early and late time points during disease progression showed development of fixed mutations in 16 predicted HIV-specific CTL epitopes. Loss of T-cell recognition and reactivity against wild-type and mutant epitopes was observed primarily for the HLA-B27-restricted KK10 epitope and HLA-A2-restricted SL9 epitope. Similarly, in patient H671, decreasing numbers of HLA-A3-restricted CD8 + T cells specific for the wild-type RK9 epitope was observed after CTL escape. Only in patient H434 loss of CTL responses was paralleled by a decrease in HIV-specific IL-2 + CD4 + T-helper responses. This suggests that loss of T-cell reactivity may not be directly linked to HIV-specific CD4 + T-cell responses but that increased viremia after CTL escape may influence CD4 + T-helper responses.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2005.09.023